Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Lactoferrin wins 3 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Mostly mechanism / observational
2 of 2 studies with measurable effects showed benefit.
Top outcomes
Verdict
Mostly mechanism / observational
Top outcomes
200–300 mg daily for adults; 100–200 mg/day for children
30–60 minutes before breakfast, Between meals on an empty stomach
Bovine lactoferrin capsule or powder (≥95% purity)
Approved (postmenopausal women) / off-label (male) — clinician-directed. For osteoporosis treatment/prevention and breast-cancer risk reduction the standard, validated dose is 60 mg once daily (the MORE, CORE, RUTH and STAR trials all used 60 mg/day; MORE also tested 120 mg/day with no clear added fracture benefit and more side effects). For off-label male gynecomastia the small published pediatric series used roughly 60 mg/day; there is no FDA-approved male dose and the male evidence is thin and retrospective.
any
Raloxifene hydrochloride 60 mg tablets (approved for postmenopausal osteoporosis and breast-cancer risk reduction)
4–8 weeks of use
4–8 weeks
4–8 weeks
6–12 weeks
Months to years
Years
Throughout use
Throughout use
Effect of Lactoferrin Supplementation on Inflammation, Immune Function, and Prevention of Respiratory Tract Infections in Humans: A Systematic Review and Meta-analysis.
Advances in Nutrition (2022) · Meta analysis
Lactoferrin significantly reduced IL-6 in adults (mean difference: -24.9 pg/mL; 95% CI: -41.64, -8.08 pg/mL)
Lactoferrin reduces the risk of respiratory tract infections: A meta-analysis of randomized controlled trials.
Clinical Nutrition ESPEN (2021) · Meta analysis
Pooled analysis of RCTs showed significant reduction in respiratory tract infection risk with lactoferrin supplementation
Comparative Effects between Oral Lactoferrin and Ferrous Sulfate Supplementation on Iron-Deficiency Anemia: A Comprehensive Review and Meta-Analysis of Clinical Trials.
Nutrients (2022) · Meta analysis
Lactoferrin was non-inferior to ferrous sulfate for increasing hemoglobin and serum ferritin
Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.
JAMA (1999) · Rct · n=7705
MORE: multicenter, randomized, double-blind, placebo-controlled trial of raloxifene 60 or 120 mg/day in 7,705 postmenopausal women with osteoporosis, followed up to 36 months
The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.
JAMA (1999) · Rct · n=7705
Pre-specified breast-cancer analysis of the MORE RCT (7,705 postmenopausal women with osteoporosis), followed a median 40 months
Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
J Natl Cancer Inst (2004) · Rct · n=5213
CORE: extension of the randomized MORE trial giving 4 additional years of raloxifene 60 mg/day (n=3,510) vs continued placebo (n=1,703)
Based on multiple meta-analyses showing OR 0.78 for RTI reduction. Effect more pronounced in children and preterm infants. Conservative estimates due to heterogeneity in populations studied.
AI-estimated from published studies. Interpret as directional guidance.
Lactoferrin has a higher evidence score (6.3/10 vs 5.3/10) and wins in 3 of 3 categories.
No known interactions between Lactoferrin and Raloxifene (Evista) have been documented in our database. However, always consult a healthcare provider before combining supplements.